Tops & Flops Stocks
Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Jaguar Health Inc. | -4.190% | -8.209% | 152.661% | -58.687% | 79.205% | -99.886% | - |
Actinium Pharmaceuticals Inc. | -4.200% | -2.115% | -3.110% | 5.195% | 79.204% | 33.884% | - |
SI-BONE Inc | -4.200% | 1.481% | -7.432% | -29.744% | -27.895% | -48.496% | - |
Sareum Holdings plc | -4.200% | -0.725% | 76.774% | -81.486% | -55.447% | -80.429% | - |
Redhill Biopharma Ltd ADR | -4.210% | - | - | - | - | - | - |
Enwave Corporation | -4.240% | -10.000% | -21.134% | -42.481% | -37.805% | -83.827% | -89.961% |
Solasia Pharma KK | -4.410% | -10.345% | -17.197% | -55.479% | -51.493% | -87.500% | - |
WAVE Life Sciences Ltd | -4.420% | -7.895% | -6.250% | 45.028% | 14.629% | 5.975% | - |
Trinity Biotech ADR | -4.440% | - | - | - | - | - | - |
Pharmaxis Ltd. | -4.550% | - | - | - | - | - | - |
CEL-SCI Corp. | -4.590% | -13.416% | -16.897% | -46.653% | -48.721% | -92.218% | - |
Visiomed Group | -4.620% | 3.795% | -6.061% | -53.266% | -27.907% | -55.202% | - |
Immuron | -4.630% | -8.850% | -26.429% | -8.036% | 23.353% | -55.217% | - |
Cellectar BioSciences Inc. | -4.670% | -10.063% | -12.270% | 120.000% | 25.439% | -73.519% | - |
Cumberland Pharmaceuticals | -4.690% | - | - | - | - | - | - |
Oncolytics Biotech | -4.730% | - | - | - | - | - | - |
Fuji Pharma Co. Ltd. | -4.740% | -6.218% | -6.701% | 6.471% | -18.468% | -1.093% | -26.435% |
InVivo Therapeutics Holdings | -4.790% | 2.581% | 0.000% | -75.195% | -53.779% | -99.933% | -99.961% |
Isoray Inc. | -4.820% | -3.571% | 14.894% | 172.269% | 293.204% | 140.000% | 303.990% |
Paion AG | -4.910% | - | - | - | - | - | - |
Lumos Pharma Inc. | -4.960% | -2.878% | 7.143% | -8.163% | -7.534% | -74.286% | -80.916% |
BeiGene Ltd ADR | -5.100% | -0.662% | 7.914% | -33.036% | -9.091% | -40.000% | - |
Brookdale Sr Lvg | -5.150% | -3.731% | 3.200% | 80.168% | 19.444% | 7.500% | 2.300% |
Erytech Pharma S.A. | -5.170% | - | - | - | - | - | - |
Prescient Therapeutics Ltd. | -5.170% | - | - | - | - | - | - |